These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10580546)
21. Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity. Mueller M; Yuan J; Maldonado Adrian C; McCann UD; Ricaurte GA Synapse; 2011 Oct; 65(10):983-90. PubMed ID: 21360595 [TBL] [Abstract][Full Text] [Related]
22. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001 [TBL] [Abstract][Full Text] [Related]
23. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X; Baumann MH; Xu H; Rothman RB Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556 [TBL] [Abstract][Full Text] [Related]
24. Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations. da Silva DD; Silva E; Carvalho F; Carmo H J Appl Toxicol; 2014 Jun; 34(6):618-27. PubMed ID: 23670916 [TBL] [Abstract][Full Text] [Related]
25. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743 [TBL] [Abstract][Full Text] [Related]
26. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats. Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722 [TBL] [Abstract][Full Text] [Related]
27. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Izco M; Orio L; O'Shea E; Colado MI Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928 [TBL] [Abstract][Full Text] [Related]
28. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G; Yeh SY; De Souza EB Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449 [TBL] [Abstract][Full Text] [Related]
29. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI; Green AR Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800 [TBL] [Abstract][Full Text] [Related]
30. Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes. Barbosa DJ; Capela JP; Oliveira JM; Silva R; Ferreira LM; Siopa F; Branco PS; Fernandes E; Duarte JA; de Lourdes Bastos M; Carvalho F Br J Pharmacol; 2012 Feb; 165(4b):1017-33. PubMed ID: 21506960 [TBL] [Abstract][Full Text] [Related]
31. The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations. Barbosa DJ; Capela JP; Silva R; Vilas-Boas V; Ferreira LM; Branco PS; Fernandes E; Bastos Mde L; Carvalho F Arch Toxicol; 2014 Feb; 88(2):455-73. PubMed ID: 24101030 [TBL] [Abstract][Full Text] [Related]
32. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY; Hsu FL Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [TBL] [Abstract][Full Text] [Related]
33. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986 [TBL] [Abstract][Full Text] [Related]
34. Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases. Schwaninger AE; Meyer MR; Zapp J; Maurer HH Toxicol Lett; 2011 Apr; 202(2):120-8. PubMed ID: 21295122 [TBL] [Abstract][Full Text] [Related]
35. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
36. The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Carvalho F; Bastos ML Toxicology; 2004 Aug; 200(2-3):193-203. PubMed ID: 15212815 [TBL] [Abstract][Full Text] [Related]
37. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine. Hashimoto K; Goromaru T Fundam Clin Pharmacol; 1990; 4(6):635-41. PubMed ID: 1710592 [TBL] [Abstract][Full Text] [Related]
39. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. Adori C; Andó RD; Kovács GG; Bagdy G J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678 [TBL] [Abstract][Full Text] [Related]
40. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy"). Colado MI; Granados R; O'Shea E; Esteban B; Green AR Pharmacol Toxicol; 1999 Jun; 84(6):261-6. PubMed ID: 10401727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]